To compare the cost-effectiveness of three patellar tendinopathy treatments.
Design:
Secondary (cost-effectiveness) analysis of a blinded, randomised controlled trial, with follow-up at 10 and 22 weeks.
Settings:
Recruitment was performed in sport clubs. The diagnosis and the intervention were carried out at San Jorge University.
Participants:
The participants were adults between 18 and 45 years (n = 48) with patellar tendinopathy.
Interventions:
Participants received percutaneous needle electrolysis, dry needling or sham needling, all of which were combined with eccentric exercise.
Main outcome measures:
Costs, quality-adjusted life years and incremental cost-effectiveness ratio were calculated for each group.
Results:
The total cost per session was similar in the three groups: €9.46 for the percutaneous needle electrolysis group; €9.44 for the dry needling group; and €8.96 for the sham group. The percutaneous needle electrolysis group presented better cost-effectiveness in terms of quality-adjusted life years and 96% and 93% probability of being cost-effective compared to the sham and dry needling groups, respectively.
Conclusion:
Our study shows that percutaneous needle electrolysis has a greater probability of being cost-effective than sham or dry needling treatment.
KnoblochK. The role of tendon microcirculation in Achilles and patellar tendinopathy. J Orthop Surg Res2008; 3: 18.
3.
MaffulliNWongJAlmekindersLC. Types and epidemiology of tendinopathy. Clin Sports Med2003; 22(4): 675–692.
4.
AlfredsonHOhbergL. Neovascularisation in chronic painful patellar tendinosis – promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surg Sports Traumatol Arthrosc2005; 13(2): 74–80.
5.
FuSCWangWPauHM, et al. Increased expression of transforming growth factor-beta1 in patellar tendinosis. Clin Orthop Relat Res2002(400): 174–183.
6.
OhbergLLorentzonRAlfredsonH. Neovascularisation in Achilles tendons with painful tendinosis but not in normal tendons: an ultrasonographic investigation. Knee Surg Sports Traumatol Arthrosc2001; 9(4): 233–238.
7.
ZwerverJBredewegSWvan den Akker-ScheekI. Prevalence of Jumper’s knee among nonelite athletes from different sports: a cross-sectional survey. Am J Sports Med2011; 39(9): 1984–1988.
8.
Benítez-MartínezJCMartínez-RamírezPValera-GarridoF, et al. Assessment of patellar tendinopathy in professional basketball players using algometry. Rev Fisioter Invasiva2019; 2: 2–8.
9.
LianOBEngebretsenLBahrR. Prevalence of jumper’s knee among elite athletes from different sports – a cross-sectional study. Am J Sports Med2005; 33(4): 561–567.
10.
HagglundMZwerverJEkstrandJ. Epidemiology of patellar tendinopathy in elite male soccer players. Am J Sports Med2011; 39(9): 1906–1911.
11.
LopesADHespanhol JuniorLCKamperSJ, et al. Exercise for patellar tendinopathy. Cochrane Database of Systematic Reviews2018; 7: CD013078.
12.
FigueroaDFigueroaFCalvoR. Patellar tendinopathy: diagnosis and treatment. J Am Acad Orthop Surg2016; 24(12): e184–e192.
13.
YoungMACookJLPurdamCR, et al. Eccentric decline squat protocol offers superior results at 12 months compared with traditional eccentric protocol for patellar tendinopathy in volleyball players. Br J Sports Med2005; 39(2): 102–105.
14.
BahrRFossanBLokenS, et al. Surgical treatment compared with eccentric training for patellar tendinopathy (jumper’s knee) – a randomized, controlled trial. J Bone Joint Surg Am2006; 88(8): 1689–1698.
15.
LarssonMEHKallINilsson-HelanderK. Treatment of patellar tendinopathy – a systematic review of randomized controlled trials. Review Knee Surg Sports Traumatol Arthrosc Aug2012; 20(8): 1632–1646.
16.
GualGFort-VanmeerhaegheARomero-RodriguezD, et al. Effects of in-season inertial resistance training with eccentric overload in a sports population at risk for patellar tendinopathy. J Strength Cond Res2016; 30(7): 1834–1842.
17.
KongsgaardMKovanenVAagaardP, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports2009; 19(6): 790–802.
18.
JamesSLJAliKPocockC, et al. Ultrasound guided dry needling and autologous blood injection for patellar tendinosis. Br J Sports Med2007; 41(8): 518–521; discussion 522.
19.
López-RoyoMPRíos-DíazJGalán-DíazRM, et al. A comparative study of treatment interventions for patellar tendinopathy: a randomized controlled trial. Arch Phys Med Rehabil2021; 102(5): 967–975.
20.
Minaya MuñozFValera GarridoFSánchez IbáñezJM, et al. Estudio de coste-efectividad de la electrólisis percutánea intratisular (EPI®) en las epicondilalgias. Fisioterapia2012; 34(5): 208–215.
21.
FernándezDAl-BoloushiZBellosta-LópezP, et al. Cost-effectiveness of two dry needling interventions for plantar heel pain: a secondary analysis of an RCT. Int J Environ Res Pub Heal2021; 18(4): 1777.
22.
Fernández SanchisDCuenca ZaldivarJNCalvoS, et al. Cost-effectiveness of dry needling in the upper extremity rehabilitation of patients with stroke. Acupunct Med2022; 40: 160–168.
23.
AbatFSánchez-SánchezJLMartín-NoguerasAM, et al. Randomized controlled trial comparing the effectiveness of the ultrasound-guided galvanic electrolysis technique (USGET) versus conventional electro-physiotherapeutic treatment on patellar tendinopathy. J Exp Orthop2016; 3(1): 34.
24.
PurdamCRJonssonPAlfredsonH, et al. A pilot study of the eccentric decline squat in the management of painful chronic patellar tendinopathy. Br J Sports Med2004; 38(4): 395–397.
25.
AlfredsonHPietiläTJonssonP, et al. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med1998; 26(3): 360–366.
26.
SilbernagelKGThomeeRErikssonBI, et al. Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study. Am J Sports Med2007; 35(6): 897–906.
27.
Carvajal-FernándezÓÁlvarez-PratsDMedina-MirapeixFMinaya-MuñozF. Effects of percutaneous needle electrolysis of the patellar tendon on local and contralateral temperature, measured with infrared thermography. J Invasive Tech Phys Ther2016; 1(1): 18–25.
28.
de la Cruz TorresBAlbornoz CabelloMGarcía BermejoP, et al. Autonomic responses to ultrasound-guided percutaneous needle electrolysis of the patellar tendon in healthy male footballers. Acupunct Med2016; 34(4): 275–279.
29.
Data from: Base de datos del medicamento. Consejo General de Colegios Oficiales de Farmacéuticos (CGCOF), 2019, botplusweb.portalfarma.com
BOA ORDEN SAN/1221/2017. de 21 de julio, por la que se establecen los precios y tarifas máximas aplicables en la prestación de servicios sanitarios con medios ajenos al Sistema de Salud de Aragón2017; 74.
BOCM-20170821-1 ORDEN 727/2017, de 7 de agosto, del Consejero de Sanidad, por la que se fijan los precios públicos por la prestación de los servicios y actividades de naturaleza sanitaria de la red de centros de la Comunidad de Madrid, 2017, https://www.bocm.es/boletin/CM_Orden_BOCM/2017/08/21/BOCM-20170821-1.PDF (accessed 11 May 2020).
VilagutGFerrerMRajmilL, et al. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit2005; 19(2): 135–150.
38.
AnPanJM. Utilidades SF-6D para España. Guía de uso 2012/8. Sevilla: Cátedra de Economía de la Salud Universidad Pablo de Olavide Consejería de Salud de la Junta de Andalucía, 2012.
39.
O’BrienBJBriggsAH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res2002; 11(6): 455–468.
Vallejo-TorresLGarcía-LorenzoBSerrano-AguilarP. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ2018; 27(4): 746–761.
42.
Arias-BuríaJLMartín-SaboridoCClelandJ, et al. Cost-effectiveness evaluation of the inclusion of dry needling into an exercise program for subacromial pain syndrome: evidence from a randomized clinical trial. Pain Med2018; 19(12): 2336–2347.
